Profitability can wait, let's boost sales first
QT Vascular CEO urges patience as he picks up more patients. By KENNETH LIM
CAN profitability ever be bad for a company? Yes, if it comes at the expense of long-term sustainability, according to Eitan Konstantino, chief executive of loss-making QT Vascular.
But Mr Konstantino has a plan. He reckons that the inflatable catheter maker just has to double its sales before shifting its focus to positive earnings.
Recent approval to sell a key product in an underserved segment should give a boost to achieving that goal, but in the meantime growing sales and investing in research will remain the priority, Mr Konstantino said.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
FLCT posts 1.1% lower H1 DPU of S$0.0348 on higher vacancies, expenses
ETF popularity poised to stay as investors flock to diversification, stability
Interests of OCBC and Great Eastern’s minority shareholders are fundamentally misaligned
Aims Apac Reit posts 10.2% lower H2 DPU on enlarged unit base
VinFast’s EV ambitions get a reality check as shares plunge 65%
Stocks to watch: FLCT, Paragon Reit, AA Reit, Lendlease Global Reit, Far East Orchard, SIA